These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 31580238)
21. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation. Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414 [TBL] [Abstract][Full Text] [Related]
22. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy. Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613 [No Abstract] [Full Text] [Related]
23. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342 [TBL] [Abstract][Full Text] [Related]
24. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635 [TBL] [Abstract][Full Text] [Related]
26. The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis. Dimou FM; Mehta HB; Adhikari D; Harland RC; Riall TS; Kuo YF Surgery; 2016 Dec; 160(6):1533-1543. PubMed ID: 27554622 [TBL] [Abstract][Full Text] [Related]
27. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation. Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770 [TBL] [Abstract][Full Text] [Related]
28. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation. Kappus M; Abdelmalek M Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816 [TBL] [Abstract][Full Text] [Related]
29. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis. Thuluvath PJ; Hanish S; Savva Y Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186 [TBL] [Abstract][Full Text] [Related]
31. The Changing Liver Transplant Recipient: From Hepatitis C to Nonalcoholic Steatohepatitis and Alcohol. Vyhmeister R; Enestvedt CK Clin Liver Dis; 2021 Feb; 25(1):137-155. PubMed ID: 33978575 [TBL] [Abstract][Full Text] [Related]
32. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis. Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807 [TBL] [Abstract][Full Text] [Related]
33. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant. Chandrakumaran A; Siddiqui MS Gastroenterol Clin North Am; 2020 Mar; 49(1):165-178. PubMed ID: 32033762 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697 [TBL] [Abstract][Full Text] [Related]
35. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis. Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296 [TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. Doycheva I; Issa D; Watt KD; Lopez R; Rifai G; Alkhouri N J Clin Gastroenterol; 2018 Apr; 52(4):339-346. PubMed ID: 28961576 [TBL] [Abstract][Full Text] [Related]
38. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study. Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S; J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367 [TBL] [Abstract][Full Text] [Related]
39. Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities. Shaker M; Tabbaa A; Albeldawi M; Alkhouri N World J Gastroenterol; 2014 May; 20(18):5320-30. PubMed ID: 24833862 [TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context. Schild MH; Guy CD Surg Pathol Clin; 2018 Jun; 11(2):267-285. PubMed ID: 29751874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]